ArticleThe Journal of biological chemistry2012

Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy.

Arunava Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.